UB Paderborn / Katalog / Suche / in CDI

Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model

Nephrology, dialysis, transplantation, 2008-04, Vol.23 (4), p.1166-1172

2008

Volltextzugriff (PDF)

Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets

American Journal of Physiology: Cell Physiology, 2011-02, Vol.300 (2), p.C226-C231

2011

Volltextzugriff (PDF)

Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis

PloS one, 2015-04, Vol.10 (4), p.e0124510-e0124510

2015

Volltextzugriff (PDF)

A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates

Journal of cerebral blood flow and metabolism, 2010-05, Vol.30 (5), p.904-912

2010

Volltextzugriff (PDF)

Diabetic nephropathy: a disorder of oxygen metabolism?

Nature reviews. Nephrology, 2010-02, Vol.6 (2), p.83

2010

Volltextzugriff (PDF)

A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia

Arteriosclerosis, thrombosis, and vascular biology, 2007-12, Vol.27 (12), p.2548

2007

Volltextzugriff (PDF)

A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration

Arteriosclerosis, thrombosis, and vascular biology, 2013-05, Vol.33 (5), p.935

2013

Volltextzugriff (PDF)

Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?

Kidney international, 2013-10, Vol.84 (4), p.693-702

2013

Volltextzugriff (PDF)

New era for drug discovery and development in renal disease

Nature reviews. Nephrology, 2011-08, Vol.7 (8), p.469

2011

Volltextzugriff (PDF)

A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models

Nephrology, dialysis, transplantation, 2008-02, Vol.23 (2), p.497-509

2008

Volltextzugriff (PDF)

Translation of basic science into clinical medicine: novel targets for diabetic nephropathy

Nephrology, dialysis, transplantation, 2009-05, Vol.24 (5), p.1373-1377

2009

Volltextzugriff (PDF)

Renal catabolism of advanced glycation end products: The fate of pentosidine

Kidney international, 1998-02, Vol.53 (2), p.416-422

1998

Volltextzugriff (PDF)

Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds

Kidney international, 2000-07, Vol.58 (1), p.425-435

2000

Volltextzugriff (PDF)

Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis

Arteriosclerosis, thrombosis, and vascular biology, 2008-04, Vol.28 (4), p.672

2008

Volltextzugriff (PDF)

Inhibition of Plasminogen Activator Inhibitor Type‐1 Activity Enhances Rapid and Sustainable Hematopoietic Regeneration

Stem cells (Dayton, Ohio), 2014-04, Vol.32 (4), p.946-958

2014

Volltextzugriff (PDF)

Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering

Journal of the American Society of Nephrology, 2005-12, Vol.16 (12), p.3631-3641

2005

Volltextzugriff (PDF)

Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: A prospective post-mortem study

Kidney international, 1997-06, Vol.51 (6), p.1928-1932

1997

Volltextzugriff (PDF)

Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications

Kidney international, 1999-02, Vol.55 (2), p.389-399

1999

Volltextzugriff (PDF)

Beechnuts and outbreaks of nephropathia epidemica (NE): of mast, mice and men

Nephrology, dialysis, transplantation, 2010-06, Vol.25 (6), p.1740-1746

2010

Volltextzugriff (PDF)

Body Weight Control by a High-Carbohydrate/Low-Fat Diet Slows the Progression of Diabetic Kidney Damage in an Obese, Hypertensive, Type 2 Diabetic Rat Model

Journal of Obesity, 2010-01, Vol.2010, p.1-11

2010

Volltextzugriff (PDF)

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model

Journal of the American Society of Nephrology, 2003-05, Vol.14 (5), p.1212-1222

2003

Volltextzugriff (PDF)

A Severe Diabetic Nephropathy Model With Early Development of Nodule-Like Lesions Induced by Megsin Overexpression in RAGE/iNOS Transgenic Mice

Diabetes (New York, N.Y.), 2006-02, Vol.55 (2), p.356-366

2006

Volltextzugriff (PDF)

Relevance of oxidative and carbonyl stress to long-term uremic complications

Kidney international, 2000-08, Vol.58 (S76), p.S120-S125

2000

Volltextzugriff (PDF)

P.-P. Lambert et les débuts de la néphrologie à Bruxelles

Néphrologie & thérapeutique, 2010-12, Vol.6 (7), p.610-611

van Ypersele de Strihou, Charles

2010

Volltextzugriff (PDF)

Advanced glycation and lipoxidation end products: reactive carbonyl compounds‐related uraemic toxicity

Nephrology, dialysis, transplantation, 2001-01, Vol.16 (suppl-4), p.8-11

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Cobalt ameliorates renal injury in an obese, hypertensive type 2 diabetes rat model

Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets

Plasminogen Activator Inhibitor-1 Antagonist TM5484 Attenuates Demyelination and Axonal Degeneration in a Mice Model of Multiple Sclerosis

A novel inhibitor of plasminogen activator inhibitor-1 provides antithrombotic benefits devoid of bleeding effect in nonhuman primates

Diabetic nephropathy: a disorder of oxygen metabolism?

A novel class of prolyl hydroxylase inhibitors induces angiogenesis and exerts organ protection against ischemia

A small molecule inhibitor to plasminogen activator inhibitor 1 inhibits macrophage migration

Diabetic nephropathy: are there new and potentially promising therapies targeting oxygen biology?

New era for drug discovery and development in renal disease

A novel class of advanced glycation inhibitors ameliorates renal and cardiovascular damage in experimental rat models

Translation of basic science into clinical medicine: novel targets for diabetic nephropathy

Renal catabolism of advanced glycation end products: The fate of pentosidine

Advanced glycation and lipidoxidation of the peritoneal membrane: Respective roles of serum and peritoneal fluid reactive carbonyl compounds

Inhibition of plasminogen activator inhibitor-1: its mechanism and effectiveness on coagulation and fibrosis

Inhibition of Plasminogen Activator Inhibitor Type‐1 Activity Enhances Rapid and Sustainable Hematopoietic Regeneration

Renoprotective properties of angiotensin receptor blockers beyond blood pressure lowering

Histological prevalence of β2-microglobulin amyloidosis in hemodialysis: A prospective post-mortem study

Alterations in nonenzymatic biochemistry in uremia: Origin and significance of “carbonyl stress” in long-term uremic complications

Beechnuts and outbreaks of nephropathia epidemica (NE): of mast, mice and men

Body Weight Control by a High-Carbohydrate/Low-Fat Diet Slows the Progression of Diabetic Kidney Damage in an Obese, Hypertensive, Type 2 Diabetic Rat Model

Anti-hypertensive agents inhibit in vivo the formation of advanced glycation end products and improve renal damage in a type 2 diabetic nephropathy rat model

A Severe Diabetic Nephropathy Model With Early Development of Nodule-Like Lesions Induced by Megsin Overexpression in RAGE/iNOS Transgenic Mice

Relevance of oxidative and carbonyl stress to long-term uremic complications

P.-P. Lambert et les débuts de la néphrologie à Bruxelles

Advanced glycation and lipoxidation end products: reactive carbonyl compounds‐related uraemic toxicity

Suchergebnisse filtern